Detalles de la búsqueda
1.
Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.
Proc Natl Acad Sci U S A
; 118(7)2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558238
2.
Predictive Factors of Non-Response to Vismodegib in Locally Advanced Basal-Cell Carcinoma.
Dermatology
; 237(6): 1023-1028, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33472195
3.
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Ann Rheum Dis
; 77(3): 393-398, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146737
4.
Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature.
J Eur Acad Dermatol Venereol
; 37(12): e1420-e1422, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458522
5.
Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo.
J Am Acad Dermatol
; 76(5): 863-870, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28094061
6.
Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass.
Ann Rheum Dis
; 78(7): e71, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29925509
7.
Radiation-induced Bullous Lichen Planus: An Isomorphic Manifestation of Radiotherapy.
Acta Derm Venereol
; 99(11): 1033-1034, 2019 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289839
8.
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.
Crit Rev Oncol Hematol
; 200: 104385, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810843
9.
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.
Crit Rev Oncol Hematol
; 199: 104384, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762217
10.
Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas.
J Cancer Res Clin Oncol
; 150(3): 133, 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492114
11.
Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma.
J Geriatr Oncol
; 12(7): 1110-1113, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736973
12.
Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study.
J Oncol
; 2021: 5524685, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33995528
13.
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional study.
JAAD Int
; 5: 112-120, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34712997
14.
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events.
Eur J Cancer
; 157: 474-484, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649118
15.
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950838
16.
A Th2 cytokine interleukin-31 signature in a case of sporadic lichen amyloidosis.
Acta Derm Venereol
; 95(2): 223-4, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24573820
17.
Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies.
G Ital Dermatol Venereol
; 154(4): 435-443, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650959
18.
UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis.
Oncogenesis
; 8(10): 52, 2019 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31551419
19.
Loss of Epidermal HIF-1α Blocks UVB-Induced Tumorigenesis by Affecting DNA Repair Capacity and Oxidative Stress.
J Invest Dermatol
; 139(9): 2016-2028.e7, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30878676
20.
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.
J Immunother Cancer
; 7(1): 337, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796119